An Exploratory Analysis of Fecal Immunochemical Test Performance for Colorectal Cancer Screening in Nigeria
The fecal immunochemical test (FIT) for hemoglobin is recommended for colorectal cancer (CRC) screening in resource-limited environments. However, there are several unique variables that may alter FIT performance in this setting, including endemic intestinal parasites and high ambient temperature. This prospective study evaluated the performance of FIT in asymptomatic, average-risk individuals of screening age in rural Nigeria.
Three hundred and twenty-four community volunteers completed a questionnaire and provided stool specimens for parasitology and microbiome analysis. Specimens were frozen and stored at −80 °C. Of 324 subjects, 139 met criteria for average-risk CRC screening and had a stool sample for analysis. These were thawed and tested with a qualitative FIT. Specimens positive for occult blood were retested every two days to evaluate the impact of time and temperature on test performance.
Of 139 individuals, 69 (49.6%) were positive for intestinal parasites and 10 (7.2%) were positive for occult blood. The most common pathogen was Cryptosporidium (40.6%). Among patients with intestinal parasites, 10.1% (7/69) had a positive FIT. Only 4.3% (3/70) of patients without parasites had a positive FIT (p = 0.208). On bivariate analysis, sociodemographic variables were not associated with a positive FIT result. Thirty percent (3/10) of the FIT-positive specimens became FIT-negative with routine storage.
Although a positive FIT result was more common in those with parasitic infection, the relationship was not significant in this small cohort. The impact of high ambient temperature on test positivity may necessitate shorter processing time guidelines for equatorial countries. Additional prospective studies are needed to validate FIT performance in Nigeria.
The Global Cancer Disparities Initiative is funded by Memorial Sloan Kettering Cancer Center, with support from the Thompson Family Foundation. This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748. The authors would like to acknowledge the dedicated surgical research team at OAUTHC for their help with data entry and stool specimen processing.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 8.Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA et al (2017) Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US multi-society task force on colorectal cancer. Gastroenterology 152(5):1217–1237.e3CrossRefPubMedGoogle Scholar
- 13.Sharp L, Tilson L, Whyte S, O'Ceilleachair A, Walsh C, Usher C et al (2012) Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy. Br J Cancer 106(5):805–816CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Alatise OI, Ayandipo OO, Adeyeye A, Seier K, Komolafe AO, Bojuwoye MO et al (2018) A symptom-based model to predict colorectal cancer in low-resource countries: results from a prospective study of patients at high risk for colorectal cancer. Cancer 124(13):2766–2773CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Grazzini G, Ventura L, Zappa M, Ciatto S, Confortini M, Rapi S et al (2010) Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district. Gut 59(11):1511–1515CrossRefPubMedGoogle Scholar
- 25.Bustinduy AL, Sousa-Figueiredo JC, Adriko M, Betson M, Fenwick A, Kabatereine N et al (2013) Fecal occult blood and fecal calprotectin as point-of-care markers of intestinal morbidity in Ugandan children with Schistosoma mansoni infection. PLoS Negl Trop Dis 7(11):e2542CrossRefPubMedPubMedCentralGoogle Scholar
- 29.Ugwuoke HJ, Okonkwo BC, Oshilonyah HU (2013) Faecel occult blood and intestinal parasites among patients attending out patient clinic in Agbor, Delta State Nigeria. Arch Biomed Sci Health 1(1):20–28Google Scholar
- 34.Parkin DM, Ferlay J, Jemal A, Borok M, Manraj SS, N'da GG, Ogunbiyi FJ, Liu B, Bray F (eds) (2018) Cancer in sub-Sahara Africa, International Agency for Research on Cancer, Scientific Publication No. 167. https://publications.iarc.fr. Accessed 3 Feb 2019
- 39.Chen H, Werner S, Brenner H (2017) Fresh vs frozen samples and ambient temperature have little effect on detection of colorectal cancer or adenomas by a fecal immunochemical test in a colorectal cancer screening cohort in Germany. Clin Gastroenterol Hepatol 15(10):1547–1556.e5CrossRefPubMedGoogle Scholar